1,3-Diethyl 2-[2-(4-chlorophenyl)-2-oxoethyl]-2-hydroxypropanedioate

Catalog No. :
ACDIGZ663
CAS No. :
400086-35-3
Molecular Formula :
C15H17ClO6
Molecular Weight :
328.75

IUPAC Name:diethyl 2-(2-(4-chlorophenyl)-2-oxoethyl)-2-hydroxymalonate

1,3-Diethyl 2-[2-(4-chlorophenyl)-2-oxoethyl]-2-hydroxypropanedioate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$147.00Login to see priceInquiryInquiry
1g90%$294.00Login to see priceInquiryInquiry
5g90%$882.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Diethyl 2-[2-(4-chlorophenyl)-2-oxoethyl]-2-hydroxypropanedioate
IUPAC Namediethyl 2-(2-(4-chlorophenyl)-2-oxoethyl)-2-hydroxymalonate
MDL No.MFCD01936425
Molecular FormulaC15H17ClO6
Molecular Weight328.75
SMILESO=C(OCC)C(O)(CC(C1=CC=C(Cl)C=C1)=O)C(OCC)=O
InChI KeyBGJZWHBQVHWIKQ-UHFFFAOYSA-N
Synonym1,3-diethyl 2-[2-(4-chlorophenyl)-2-oxoethyl]-2-hydroxypropanedioate;Propanedioic acid, 2-[2-(4-chlorophenyl)-2-oxoethyl]-2-hydroxy-, 1,3-diethyl ester;Diethyl 2-[2-(4-chlorophenyl)-2-oxo-ethyl]-2-hydroxy-propanedioate
CAS No.400086-35-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACDIGZ663 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDIGZ663 route product structure diagram
    ACDIGZ663400086-35-3
Inquiry

2. ACDIGZ663 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDIGZ663 route product structure diagram
    ACDIGZ663400086-35-3
Inquiry

Comments (0)